PNC Financial Services Group’s BioStem Technologies BSEM Stock Holding History

PNC Financial Services Group’s Portfolio BSEM Stock Details BSEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.68M	Buy	+543,847	New	+$2.07M	﹤0.01%	1173

Other funds holding BSEM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Anson Funds Management Dallas, Texas $1.82B AUM 38.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Elequin Capital New York $1.47B AUM 5.26% 1-Year Est. Return

Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $225B AUM

Beaird Harris Wealth Management Dallas, Texas $1.55B AUM 10.67% 1-Year Est. Return

PNC Financial Services Group's BSEM Position: Q3 2026 in Review

PNC Financial Services Group opened a new position in BioStem Technologies (BSEM) in Q3 2026: 543,847 shares worth $1.68M. The stake represents ﹤0.01% of the portfolio and ranks #1173 among its holdings.

19 funds tracked by Wall St. Rank hold BSEM as of Q3 2026.

PNC Financial Services Group held 543,847 shares of BioStem Technologies worth $1.68M as of Q3 2026.
BioStem Technologies was a new PNC Financial Services Group position in Q3 2026.
BioStem Technologies made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1173 holding.
19 funds tracked by Wall St. Rank held BioStem Technologies as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.